Regulation of Skp2 levels by the Pim-1 protein kinase

Bo Cen1, Sandeep Mahajan, Marina Zemskova

  • 1Department of Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA.

Insights

Pim-1 protein kinase regulates cell growth by controlling p27 levels. It stabilizes Skp2 through phosphorylation, inhibiting p27 degradation and promoting cell cycle progression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Pim-1 protein kinase is crucial for cell growth, survival, and oncogenic transformation.
  • Pim-1 regulates cell growth partly by controlling levels of the cell cycle inhibitor p27.
  • The SCF(Skp2) ubiquitin ligase complex governs p27 degradation, influencing cell cycle progression.

Purpose of the Study:

  • To elucidate the mechanism by which Pim-1 regulates p27 protein levels.
  • To investigate the role of the SCF(Skp2) ubiquitin ligase complex in Pim-1-mediated p27 regulation.

Main Methods:

  • Investigated Pim-1's interaction with and phosphorylation of Skp2.
  • Identified novel phosphorylation sites on Skp2, including Thr(417).
  • Examined Pim-1's regulation of the anaphase-promoting complex/cyclosome (APC/C) and its impact on Skp2 stability.

Main Results:

  • Pim-1 directly binds and phosphorylates Skp2 at multiple sites, including the novel site Thr(417).
  • Phosphorylation of Thr(417) enhances Skp2 stability and its degradation of p27.
  • Pim-1 also phosphorylates Cdh1, impairing APC/C-mediated Skp2 ubiquitination and degradation.
  • These combined mechanisms lead to increased Skp2 and decreased p27 levels, facilitating S phase entry.

Conclusions:

  • Pim-1 activates a novel signaling pathway involving Skp2 stabilization and APC/C inhibition.
  • This pathway plays a critical role in regulating cell cycle progression by modulating p27 levels.
  • Pim-1 and Skp2 cooperate to promote entry into S phase, highlighting a key mechanism in cell cycle control.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...